Cathay Biotech Inc Capital Reinvestment Ratio
Cathay Biotech Inc capital reinvestment ratio. Cathay Biotech Inc (688065) has a Capital Reinvestment Ratio of 0.31x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥251.82 Million) in capital expenditures (CN¥78.51 Million). Check 688065 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cathay Biotech Inc (2017–2025)
Capital reinvestment ratio of Cathay Biotech Inc from 2017 to 2025. This chart tracks Cathay Biotech Inc's Capital Reinvestment Ratio across 8 annual periods. Also explore 688065 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Cathay Biotech Inc Capital Reinvestment Ratio by Year (2017–2025)
Cathay Biotech Inc capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see Cathay Biotech Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.84x | CN¥404.12 Million | CN¥743.46 Million | ▲ +79.1% |
| 2024 | 1.03x | CN¥820.93 Million | CN¥843.31 Million | ▼ -62.7% |
| 2023 | 2.76x | CN¥569.45 Million | CN¥1.57 Billion | ▼ -47.2% |
| 2022 | 5.22x | CN¥803.67 Million | CN¥4.20 Billion | ▲ +110.5% |
| 2021 | 2.48x | CN¥594.18 Million | CN¥1.47 Billion | ▲ +67.5% |
| 2020 | 1.48x | CN¥514.96 Million | CN¥763.11 Million | ▲ +4.3% |
| 2019 | 1.42x | CN¥359.62 Million | CN¥511.14 Million | ▼ -92.4% |
| 2017 | 18.62x | CN¥53.45 Million | CN¥995.09 Million | — |